Strategy
dividend growthincomeretirement
Description
No detailed brain note yet for Wealthy Retirement. USPs will populate as FID mines its promos.
Promos (0)
No analyzed promos yet.
Recent Emails
View all (116) in iSpy →- Read full email2026-08-31EDITORIALWealthy RetirementThe Biggest Mistake Retirees MakeDr. Mark Skousen discusses the psychological and financial mistakes retirees commonly make, focusing on the tension between saving and spending in retirement. The editorial argues that many wealthy retirees paradoxically save too much due to fear of outliving their money, rather than achieving true financial freedom through balanced spending.
- Read full email2026-08-31PROMOWealthy RetirementIs the bull run over?Dr. Mark Skousen presents a macroeconomic analysis claiming the AI chip bull run is cooling and predicts a major market structural shift with billions flowing into a new #1 sector for the remainder of 2026. The email directs readers to watch a video overview of his new action plan and sector prediction.
- Read full email2026-08-30PROMOWealthy RetirementWeekly Roundup - August 30, 2026This is a weekly roundup email from Oxford Club's Wealthy Retirement newsletter featuring a sponsored promotion for Marc Lichtenfeld's investigative video about a widespread legal scam. The email teases multiple investment topics (AI opportunity, 9.6% yielding asset, risk management) but leads with the fraud-exposure video as the primary CTA.
- Read full email2026-08-29PROMOWealthy RetirementDefense was the #1 sector in 2025. It's happening again.Oxford Club's Wealthy Retirement newsletter promotes Dr. Mark Skousen's video analysis of five small-cap defense suppliers positioned to benefit from increased military spending and geopolitical tensions, citing State Street's confirmation that defense was the top-performing sector in 2025.
- Read full email2026-08-29EDITORIALWealthy RetirementHow One Chat With AI Saved My LifeAlexander Green, Chief Investment Strategist at Oxford Club, uses a personal health narrative about severe muscle pain and AI-assisted diagnosis via Claude to frame Anthropic as the next major tech IPO opportunity. The email positions Anthropic as a superior alternative to OpenAI with rapid revenue scaling ($1B annually to $10B quarterly) and positions a 'backdoor' investment strategy before public listing.
- Read full email2026-08-28EDITORIALWealthy RetirementThis Biotech Stock Has Fallen Hard...Anthony Summers analyzes Recursion Pharmaceuticals (RXRX), an AI-driven biotech company, as a potential buy-the-dip opportunity after the stock collapsed from $10 to $3.48 despite clinical progress and major pharma partnerships. The company shows promising early trial data (75% of FAP patients saw polyp reduction) and Genentech validation, but faces cash burn concerns ($187M in H1 2026) that temper the investment case.
- Read full email2026-08-28EDITORIALWealthy RetirementTrump's new super deadlineRachel Gearhart of Oxford Club's Wealthy Retirement alerts readers to Trump's August 26 compliance deadline affecting specific companies with potential market implications. Dr. Mark Skousen provides analysis of the policy's market impact.
- Read full email2026-08-27PROMOWealthy RetirementThe 21-day deadline just hitRachel Gearhart promotes Mark Skousen's analysis of a Trump administration 21-day military production acceleration deadline to defense contractors that just expired. The email positions defense stocks as poised for major moves following this government policy catalyst.